Skip Navigation

Journal of Biochemistry 2004 136(5):733-740; doi:10.1093/jb/mvh180
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Takagaki, K.
Right arrow Articles by Yano, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takagaki, K.
Right arrow Articles by Yano, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 The Japanese Biochemical Society

BIOCHEMISTRY

Gene-Expression Profiling Reveals Down-Regulation of Equilibrative Nucleoside Transporter 1 (ENT1) in Ara-C–Resistant CCRF-CEM–Derived Cells

Kazuchika Takagaki*, Susumu Katsuma, Yoshinori Kaminishi, Tatsuya Horio, Shinichiro Nakagawa, Teruo Tanaka, Tadaaki Ohgi and Junichi Yano

Discovery Research Laboratories, Nippon Shinyaku Co., Ltd, 3-14-1 Sakura, Tsukuba, Ibaraki 305-0003

We have investigated the mechanism of resistance of leukemia cells to Ara-C using an in-house cDNA microarray designed for the analysis of leukemia cells. We produced Ara-C–resistant cells from the CCRF-CEM (acute lymphoblastic leukemia) cell line and compared their gene-expression profile with that of wild-type cells. The adenosine deaminase (ADA) gene was highly up-regulated in Ara-C–resistant cells, while equilibrative nucleoside transporter 1 (ENT1) and several cell-cycle–related genes were down-regulated. Of all these genes, ENT1 seemed the most likely to be relevant to Ara-C resistance. To investigate the role of ENT1 in Ara-C–resistant cells, we transfected the cells with the gene. ENT1-transfected Ara-C–resistant cells resembled wild-type CCRF-CEM cells more closely than untransfected Ara-C–resistant cells in terms of growth rate, Ara-C-uptake characteristics, and ADA expression levels. The down-regulation of the ENT1 gene is expected to result in nucleotide deficiency in addition to blockage of Ara-C influx. Accordingly, Ara-C–resistant cells showed low growth rates, which were restored by transfection with ENT1. These low growth rates were also correlated with the phosphorylation level of cell-cycle checkpoint kinase 2. In this study we identified down-regulation of ENT1 as the factor responsible for Ara-C resistance, and this knowledge may be used to devise a clinical regimen that will overcome the resistance.

* To whom correspondence should be addressed. Phone: +81-29-850-6242, Fax: +81-29-850-6217, E-mail: k.takagaki{at}nippon-shinyaku.co.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
K. D. Ibarra and J. K. Pfeiffer
Reduced Ribavirin Antiviral Efficacy via Nucleoside Transporter-Mediated Drug Resistance
J. Virol., May 1, 2009; 83(9): 4538 - 4547.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. Cai, V. L. Damaraju, N. Groulx, D. Mowles, Y. Peng, M. J. Robins, C. E. Cass, and P. Gros
Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells
Cancer Res., April 1, 2008; 68(7): 2349 - 2357.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.